Research graph
References from Investigation of a Prostate Cancer Radiation Response Signature in the Breast Cancer SweBCG91RT Randomized Trial. Local targets link to admitted publications; unresolved targets remain external evidence.
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
10.1016/s1470-2045(16)30491-0 · 2016 · External reference
Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials
10.1016/j.annonc.2025.01.017 · 2025 · External reference
PORTOS gene signature as a predictor of risk of adverse events after dose-escalated vs. lower-dose prostate radiation therapy in NRG/RTOG 0126
10.1200/jco.2025.43.5_suppl.375 · 2025 · External reference
Prognosis associated with luminal and basal subtypes of metastatic prostate cancer
10.1001/jamaoncol.2021.3987 · 2021 · External reference
Associations of luminal and basal subtyping of prostate cancer with prognosis and response to androgen deprivation therapy
10.1001/jamaoncol.2017.0751 · 2017 · External reference
Clinical and genomic implications of luminal and basal subtypes across carcinomas
10.1158/1078-0432.ccr-18-3121 · 2019 · External reference
High-purity CTC RNA sequencing identifies prostate cancer lineage phenotypes prognostic for clinical outcomes
10.1158/2159-8290.cd-24-1509 · 2025 · External reference
Validation of a breast cancer assay for radiotherapy omission: an individual participant data meta-analysis
10.1093/jnci/djae262 · 2025 · External reference
No breast cancer subgroup can be spared postoperative radiotherapy after breast-conserving surgery. Fifteen-year results from the Swedish Breast Cancer Group randomised trial, SweBCG 91 RT
10.1016/j.ejca.2016.08.001 · 2016 · External reference
Effect of radiotherapy after breast-conserving surgery depending on the presence of tumor-infiltrating lymphocytes: a long-term follow-up of the SweBCG91RT randomized trial
10.1200/jco.18.02157 · 2019 · External reference
Symptoms 10–17 years after breast cancer radiotherapy data from the randomised SWEBCG91-RT trial
10.1016/j.radonc.2010.09.018 · 2010 · External reference
Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening
10.1016/s0959-8049(03)00324-1 · 2003 · External reference
Clinicogenomic radiotherapy classifier predicting the need for intensified locoregional treatment after breast-conserving surgery for early-stage breast cancer
10.1200/jco.19.00761 · 2019 · External reference
Development and validation of a genomic profile for the omission of local adjuvant radiation in breast cancer
10.1200/jco.22.00655 · 2023 · External reference
Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors
10.1186/s13058-018-0978-y · 2018 · External reference
The analysis of failure times in the presence of competing risks
10.2307/2530374 · 1978 · External reference
A proportional hazards model for the subdistribution of a competing risk
10.2307/2670170 · 1999 · External reference
Cumulative incidence estimation in the presence of competing risks
10.1177/1536867x0400400201 · 2004 · External reference
Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring
10.1111/j.1541-0420.2010.01420.x · 2011 · External reference
Mstate: an R package for the analysis of competing risks and multi-state models
10.18637/jss.v038.i07 · 2011 · External reference
Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects
10.1002/sim.1203 · 2002 · External reference
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer
10.1056/nejmoa040587 · 2004 · External reference
The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial. Ontario Clinical Oncology Group
10.1002/(sici)1097-0142(20000515)88:10<2260::aid-cncr9>3.0.co;2-m · 2000 · External reference
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials
10.1016/s0140-6736(11)61629-2 · 2011 · External reference
